Followers | 24 |
Posts | 1479 |
Boards Moderated | 0 |
Alias Born | 10/05/2015 |
Wednesday, August 17, 2022 8:17:08 PM
Recent VERU News
- Veru to Present at the GLP-1 Based Therapeutics Summit • GlobeNewswire Inc. • 05/02/2024 12:30:00 PM
- Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:30:37 PM
- Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss • GlobeNewswire Inc. • 04/30/2024 12:30:00 PM
- Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
- Veru Announces Date of 2024 Annual Meeting of Shareholders • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- Veru Reschedules Annual Meeting of Shareholders • GlobeNewswire Inc. • 03/22/2024 08:05:00 PM
- Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q • GlobeNewswire Inc. • 02/28/2024 12:15:00 AM
- Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 09:49:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:06:36 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 12:00:37 PM
- Veru Reports Fiscal 2024 First Quarter Financial Highlights • GlobeNewswire Inc. • 02/08/2024 11:30:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 09:27:50 PM
- Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs • GlobeNewswire Inc. • 02/06/2024 01:30:00 PM
- Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 01/31/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:06:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/26/2024 02:02:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/26/2024 02:00:32 PM
- Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024 • GlobeNewswire Inc. • 01/25/2024 01:30:00 PM
- Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss • GlobeNewswire Inc. • 01/08/2024 01:30:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/26/2023 09:31:07 PM
- Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs • GlobeNewswire Inc. • 12/19/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 02:01:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM